TY - JOUR
T1 - Dobutamine-induced cardiac adaptations
T2 - Comparison with exercise-trained and sedentary rats
AU - Davidson, W. R.
AU - Banerjee, S. P.
AU - Liang, C. S.
PY - 1986
Y1 - 1986
N2 - To investigate dobutamine-induced cardiac adaptations, we compared dobutamine-treated with swim-trained and sedentary control rats. After 14 wk of treatment, heart rate was lower in the dobutamine-treated (279 ± 6) and exercise-trained (287 ± 4 beats/min) groups than in the control animals (305 ± 3 beats/min; P < 0.05). The exercised rats gained less weight (164 ± 11 g; P < 0.05) than the dobutamine-treated (238 ± 16 g) and the control animals (231 ± 12 g). Also, compared with the two other groups, the exercise group had higher relative heart weights (3.47 ± 0.08 vs. 2.82 ± 0.06 and 290 ± 0.05 g/kg in the dobutamine and control groups, respectively; P < 0.05) and lower epididymal fat pad weights (6.6 ± 0.4 vs. 13.3 ± 1.0 and 11.4 ± 0.5 g/kg in the dobutamine and control groups, respectively; P < 0.05). However, both the maximum heart rate produced by isoproterenol and the isoproterenol dose producing 50% of the peak heart rate response were similar among the three groups. Myocardial norepinephrine content, β-adrenergic receptor number, and adenylate cyclase activation by isoproterenol, NaF, 5'-guanylyl imidodiphosphate, and forskolin also did not differ. Thus, although there were differences between the dobutamine-treated and the exercised rats, the two groups were similar in that they developed bradycardia that was not due to cardiac adrenergic desensitization.
AB - To investigate dobutamine-induced cardiac adaptations, we compared dobutamine-treated with swim-trained and sedentary control rats. After 14 wk of treatment, heart rate was lower in the dobutamine-treated (279 ± 6) and exercise-trained (287 ± 4 beats/min) groups than in the control animals (305 ± 3 beats/min; P < 0.05). The exercised rats gained less weight (164 ± 11 g; P < 0.05) than the dobutamine-treated (238 ± 16 g) and the control animals (231 ± 12 g). Also, compared with the two other groups, the exercise group had higher relative heart weights (3.47 ± 0.08 vs. 2.82 ± 0.06 and 290 ± 0.05 g/kg in the dobutamine and control groups, respectively; P < 0.05) and lower epididymal fat pad weights (6.6 ± 0.4 vs. 13.3 ± 1.0 and 11.4 ± 0.5 g/kg in the dobutamine and control groups, respectively; P < 0.05). However, both the maximum heart rate produced by isoproterenol and the isoproterenol dose producing 50% of the peak heart rate response were similar among the three groups. Myocardial norepinephrine content, β-adrenergic receptor number, and adenylate cyclase activation by isoproterenol, NaF, 5'-guanylyl imidodiphosphate, and forskolin also did not differ. Thus, although there were differences between the dobutamine-treated and the exercised rats, the two groups were similar in that they developed bradycardia that was not due to cardiac adrenergic desensitization.
UR - http://www.scopus.com/inward/record.url?scp=0022540455&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022540455&partnerID=8YFLogxK
U2 - 10.1152/ajpheart.1986.250.5.h725
DO - 10.1152/ajpheart.1986.250.5.h725
M3 - Article
C2 - 3010740
AN - SCOPUS:0022540455
SN - 0363-6135
VL - 250
SP - H725-H730
JO - American Journal of Physiology - Heart and Circulatory Physiology
JF - American Journal of Physiology - Heart and Circulatory Physiology
IS - 5 (19/5)
ER -